HBM Holdings Limited

HK$10.38As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2142Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 6Y CAGR (0.29%)
Div yield —
ROE 23.97%
Biotechnology
Beta (5Y) 1.63
PE TTM 12.92
TSR TTM (22.94%)
Mkt cap HK$8.570B
ROIC 52.95%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$9.87
(4.93%)
187.79%
Hold 8|7|12|7|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.21
0.23
0.25
0.27
8.70%
20.44%
33.16%
46.27%
Revenue$M
612.6
635.8
638.9
628.9
11.85%
9.91%
7.99%
3.85%
Peers (US$1.093B)
Cap (US$)
PE
1.086B
26.50x
Capital
TTM
5Y
10Y
Leveragex
8.848
0.922
0.838
EBIT/Intx
1.187
1.218
1.026
Own earn%
(9.95)
(34.07)
3.33
Sh yield%
41.68
14.80
21.28
Owners
Insiders/Inst%
5.51
34.68
Short interest%
4.87
SBC / revenue%
2.76
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
25–40
$1 testx
0.0
Incr. ROIC%
6